glibenclamide
CONCLUSIONS: There was evidence of over-utilization       of metformin and glibenclamide in type 2 diabetes patients most at risk of       adverse reactions.
CONCLUSIONS: There was evidence of over-utilization       of metformin and  @SUBJECT$   @PREDICAT$  type 2 diabetes  @OBJECT$  most at risk of       adverse reactions.